Tag: narrow therapeutic index

Long-term follow-up: sustaining health after switching to generics
  • 29
  • Jul

Long-term follow-up: sustaining health after switching to generics

Explore the realities of long-term health after switching to generic medications. Learn about bioequivalence gaps, manufacturing risks, and strategies to maintain stability.

Theophylline Levels: Why Narrow Therapeutic Index Monitoring is Critical
  • 12
  • Jul

Theophylline Levels: Why Narrow Therapeutic Index Monitoring is Critical

Theophylline has a narrow therapeutic index (10-20 mg/L), making regular blood monitoring critical to prevent seizures and heart arrhythmias. Learn how drug interactions, smoking, and age impact levels.

Medical Society Guidelines on Generic Use: Provider Positions Explained
  • 26
  • Mar

Medical Society Guidelines on Generic Use: Provider Positions Explained

Explore official medical society guidelines on generic drug use. Learn how specialists like neurologists differ from general practice, understand narrow therapeutic indices, and see the economic trade-offs.

Should You Stay on Brand NTI Drugs When Substitution Is Allowed?
  • 4
  • Feb

Should You Stay on Brand NTI Drugs When Substitution Is Allowed?

Discover when to stay on brand-name narrow therapeutic index drugs versus switching to generics. Learn about FDA standards, real-world risks, and practical advice for common NTI medications like levothyroxine and warfarin.